Wikidata

(Q48387202)

English

Effectiveness of erlotinib as a second line therapy for patients with epidermal growth factor receptor (EGFR) mutation in non-small cell lung cancer (NSCLC): our clinical experience.

scientific article published in July 2012

In more languages

Statements

title
Effectiveness of erlotinib as a second line therapy for patients with epidermal growth factor receptor (EGFR) mutation in non-small cell lung cancer (NSCLC): our clinical experience (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22983065
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22983065%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q48387202&oldid=1114359387"